Comparison of Institutional Empirical Cephalosporin Therapy Protocol versus Standardized International Sepsis in Obstetrics Protocol in Managing Sepsis during Pregnancy and Postpartum
Keywords:
maternal sepsis, antibiotic protocol, antimicrobial resistance, cost-effectiveness, obstetric outcomesAbstract
Background: Maternal sepsis remains a leading cause of pregnancy-related mortality, contributing to 11% of global maternal deaths. While international sepsis guidelines exist, many institutions continue using empirical cephalosporin protocols despite growing antimicrobial resistance concerns. This study compared clinical and economic outcomes between institutional empirical cephalosporin therapy and standardized international sepsis protocols in obstetric patients.
Methods: A randomized controlled trial was conducted with 500 pregnant/postpartum women diagnosed with sepsis (SOFA score ≥2) at a tertiary care center. Participants were allocated to: Group A (n=250): Institutional protocol (cefoperazone-sulbactam empirical therapy). Group B (n=250): International protocol (WHO/Surviving Sepsis Campaign guidelines). Primary outcomes included clinical recovery and mortality. Secondary outcomes assessed antimicrobial resistance, healthcare utilization, and cost-effectiveness (converted to INR). Statistical analysis employed t-tests, chi-square, and Kaplan-Meier methods (SPSS v26).
Results: The international protocol demonstrated superior outcomes: 28% lower mortality (4% vs 8%, p=0.04). Faster clinical improvement (3.8 vs 4.5 days, p=0.02). 37% reduction in resistant isolates (22% vs 35%, p=0.003). 17% shorter hospital stays (6.2 vs 7.5 days, p=0.001). 21% cost savings (₹1,82,600 vs ₹2,32,400 per case, p=0.001).
Conclusion: Standardized international sepsis protocols significantly improved survival, reduced antimicrobial resistance, and decreased healthcare costs compared to institutional cephalosporin-based regimens. These findings support global guideline adoption in obstetric practice, particularly in resource-limited settings. Future research should explore implementation strategies across diverse healthcare systems.
Downloads
Metrics
References
Say L, Chou D, Gemmill A, Tunçalp Ö, Moller AB, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014 Jun;2(6):e323-33.
Sharma NS, Wille KM, Athira S, Zhi D, Thannickal VJ, Harada RN, et al. The alveolar epithelial cell chemokine response to respiratory syncytial virus infection in pregnancy. Am J Reprod Immunol. 2017 Nov;78(5):e12716.
Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013 Feb;39(2):165-228.
Bookstaver PB, Bland CM, Griffin B, Stover KR, Eiland LS, McLaughlin M. A review of antibiotic use in pregnancy. Pharmacotherapy. 2015 Jul;35(7):e82-8.
Bauer M, Gerlach H, Vogelmann T, Preissing F, Stiefel J, Adam D. Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019—results from a systematic review and meta-analysis. Crit Care Med. 2020 Jan;48(1):66-73.
Bowyer L, Robinson HL, Barrett H, Crozier TM, Giles M, Idel I, et al. SOMANZ position statement on the management of sepsis in pregnancy. Aust N Z J Obstet Gynaecol. 2017 Dec;57(6):e251-e269.
Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA. 2009 Nov 4;302(17):1896-902.
Acosta CD, Kurinczuk JJ, Lucas DN, Tuffnell DJ, Sellers S, Knight M. Severe maternal sepsis in the UK, 2011-2012: a national case-control study. PLoS Med. 2014 Jul 29;11(7):e1001672.
Bonet M, Nogueira Pileggi V, Rijken MJ, Coomarasamy A, Lissauer D, Souza JP, et al. Towards a consensus definition of maternal sepsis: results of a systematic review and expert consultation. Reprod Health. 2017;14(1):67.
Bauer ME, Bateman BT, Bauer ST, Shanks AM, Mhyre JM. Maternal sepsis mortality and morbidity during hospitalization for delivery: temporal trends and independent associations for severe sepsis. Anesth Analg. 2013;117(4):944-50.
Indian Council of Medical Research. Annual Report Antimicrobial Resistance Surveillance and Research Network 2021. New Delhi: ICMR; 2022.
Mathur M, Swaminathan S, Dutta S, Ghosh S, Nair P, Singh S. Impact of a structured sepsis protocol on outcomes in obstetric patients: a multicenter study from India. J Obstet Gynaecol India. 2021;71(3):256-63.
Patil S, Raut A, Bhalerao A. Cost-effectiveness of protocolized sepsis care in public hospitals: experience from Maharashtra. Indian J Crit Care Med. 2023;27(1):32-8.
..
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
